1. Photodynamic Therapy Versus Combination Therapy in Polypoidal Choroidal Vasculopathy: Changes of Aqueous Vascular Endothelial Growth Factor
- Author
-
Oh Woong Kwon, Won Ki Lee, Mee Yon Lee, Jin Hae Lee, and Jiwon Baek
- Subjects
Indocyanine Green ,Male ,Vascular Endothelial Growth Factor A ,medicine.medical_specialty ,genetic structures ,Combination therapy ,medicine.medical_treatment ,Visual Acuity ,Angiogenesis Inhibitors ,Photodynamic therapy ,Antibodies, Monoclonal, Humanized ,complex mixtures ,law.invention ,Aqueous Humor ,chemistry.chemical_compound ,Polyps ,Randomized controlled trial ,law ,Ranibizumab ,Ophthalmology ,medicine ,Humans ,Prospective Studies ,Fluorescein Angiography ,Coloring Agents ,Aged ,Immunoassay ,Microscopy, Confocal ,Choroid ,business.industry ,Choroid Diseases ,Middle Aged ,Cataract surgery ,Combined Modality Therapy ,eye diseases ,Vascular endothelial growth factor ,Photochemotherapy ,chemistry ,Concomitant ,Intravitreal Injections ,Female ,sense organs ,business ,After treatment ,medicine.drug - Abstract
Purpose To investigate the influence of photodynamic therapy (PDT) and combination of PDT and ranibizumab on aqueous humor levels of vascular endothelial growth factor (VEGF) in polypoidal choroidal vasculopathy (PCV). Design Prospective randomized clinical trial. Method We included 20 eyes with treatment-naive PCV and 20 eyes undergoing cataract surgery as controls. PCV eyes were randomized to treatment with PDT alone or to a combination of ranibizumab and PDT on the same day. During 3 months, retreatment was not performed. Aqueous humors were collected at baseline and at 1 week, 1 month, and 3 months after treatment in the PCV group and during cataract surgery in the control group. VEGF levels were measured using multiplex bead immunoassay. Results At baseline, VEGF levels were significantly increased in PCV eyes compared with control eyes. A significant decrease in VEGF levels was found at 1 week after PDT treatment (n = 8) and at all time points after combination treatment (n = 12). With combination treatment, VEGF levels were decreased to values below the detection limit in all eyes at 1 week and 1 month and in 7 of 12 eyes at 3 months. There was no difference in the clinical profiles among the 2 treatment groups at each time point. Conclusion Decreased levels of VEGF detected 1 week after PDT for PCV seems to reflect acute damage of vascular endothelial cells, one of the VEGF expression sites in PCV. Concomitant ranibizumab resulted in a further decrease in VEGF to negligible levels, but this result did not affect the clinical results for 3 months.
- Published
- 2013